Becton, Dickinson and Company (BDXB) Stock Analysis
DELISTED 2023
What happened to Becton, Dickinson and Company (BDXB) stock?
Becton, Dickinson and Company (BDXB) no longer trades on public markets. It was delisted in May 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- May 2023
- Last recorded price (historical):
- $48.16 (last quote on record before the May 2023 delisting; historical, not a current quote)
P/E 14.51 means the share price is 14.51 times one year of earnings per share. Market cap $13.7B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Becton, Dickinson and Company (BDXB). Becton, Dickinson and Company (BDXB) is a global medical technology company that develops, manufactures, and sells a wide range of medical supplies, devices, laboratory equipment, and diagnostic products.
Last analyzed: Mar 17, 2026Becton, Dickinson and Company (BDXB) Healthcare & Pipeline Overview
More about this archive record
Can I still buy BDXB shares?
No. BDXB stopped trading on public markets in May 2023, so the shares are not available through a broker. Anything you see quoted for BDXB elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BDXB stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Becton, Dickinson and Company. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.